$20.00

i 2.00 Hours

Course Overview

Hypercoagulability disorder is a highly prevalent clinical condition characterized by abnormal blood coagulation, which leads to thrombosis inside the blood vessels. The most common clinical manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE); both are types of venous thromboembolism (VTE). DVT may result from the formation of blood clots in the peripheral vascular bed. PE is a life-threatening condition caused by blockage in major pulmonary vessels that rapidly progresses to cardiogenic shock, circulatory failure, and death. VTE can also occur in other sites, including the veins in the brain, kidneys, liver, mesenteric circulation, arms, and legs. The challenge in managing hypercoagulability disorders is due to the clinical variability of the disease etiology and numerous possible sites of blockage balanced against treatment objectives, outcomes, and cost. This continuing education module focuses on reviewing, for multiple healthcare professionals, the various features and risk factors of VTE and the evidence based guidelines for prophylaxis and treatment. The module also briefly discusses inherited hypercoagulability conditions, such as antiphospholipid syndrome and activated protein C resistance (e.g., factor V Leiden).

About the Course Author

Kawshik Chowdhury is Pharmacy Manager of Atlantic Medical Center as well as an Educational Content Writer for Mometrix Test Preparation Kawshik Chowdhury, RPh, PhD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!


Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (17 Match)

  • American Nurses Credentialing Center

    2.00HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Nurses will receive 2.0 Nursing Contact Hours after successfully completing this course.
  • California Board of Registered Nursing

    2.00HOURS

    Provider approved by the California Board of Registered Nursing, CEP# 13791 Nurses will receive 2.0 contact hours for participating in this course.
  • District of Columbia Board of Nursing

    2.00HOURS


    District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).

    Nurses will receive 2.0 contact hours for participating in this course.
  • Florida Board of Nursing

    2.00HOURS


    Florida Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 2.0 contact hours for participating in this course.
  • Commission on Dietetic Registration

    2.00HOURS


    As a Jointly Accredited organization, Relias LLC is accredited to offer dietetic continuing education by the Commission on Dietetic Registration (CDR). The CDR is an associate member of Joint Accreditation for Interprofessional Continuing Education.

  • Florida Council of Dietetics and Nutrition

    2.00HOURS


    Florida Council of Dietetics and Nutrition (CEBroker Provider #50-290)

    This course is approved for 2.0 contact hours.
  • Georgia Board of Nursing

    2.00HOURS


    Georgia Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 2.0 contact hours for participating in this course.
  • Accreditation Council for Continuing Medical Education

    2.00HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Relias LLC designates this enduring activity for a maximum of 2.0 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • South Carolina Board of Nursing

    2.00HOURS


    South Carolina Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 2.0 contact hours for participating in this course.
  • Florida Board of Medicine

    2.00HOURS


    Florida Board of Medicine (CEBroker Provider #50-290)

    Physicians will receive 2.0 AMA PRA category 1 Credits™.
  • West Virginia Board of Registered Nursing

    2.00HOURS


    West Virginia Board of Registered Nursing (CEBroker Provider #50-290)

    Nurses will receive 2.0 contact hours for participating in this course.
  • Accreditation Council for Pharmacy Education

    2.00HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Type Activity: Knowledge
    Target Audience Designation: P
    ACPE Universal Activity Number: JA4008266-0000-21-146-H01-P
  • New Mexico Board of Nursing

    2.00HOURS


    New Mexico Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 2.0 contact hours for participating in this course.
  • Arkansas State Board of Nursing

    2.00HOURS


    Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).

    Nurses will receive 2.0 contact hours for participating in this course.
  • Ohio State Medical Board

    2.00HOURS


    State Medical Board of Ohio (CEBroker Provider #: 50-290)

    Physicians will receive 2.0 AMA PRA category 1 Credits™.
  • Louisiana State Board of Medical Examiners

    2.00HOURS


    Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)

    Physicians will receive 2.0 AMA PRA category 1 Credits™.
  • Mississippi State Board of Medical Licensure

    2.00HOURS


    Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)

    Physicians will receive 2.0 AMA PRA category 1 Credits™.


Course Details
  • Course Code:

    REL-ACU-0-PHARMMVT
  • Hours:

    2.00
  • Type:

    Online Course
  • Release Date:

    2019-10-01
  • Expiration Date:

    2022-08-07
  • Learning Objectives:

    Analyze treatment modalities and identify goals of therapy in the management of VTE and how various members of the healthcare team can contribute to the care process; Describe the tests and tools available to assess the risk of developing a blood clot; Discuss challenges encountered with patient adherence to anticoagulant therapy; Identify risk factors and symptoms associated with hypercoagulability disorders, including deep vein thrombosis and pulmonary embolism; Review how evidence-based guidelines for the prevention and treatment of VTE can be used by the healthcare team; Review key patient education points that the healthcare team should emphasize regarding the symptoms of thrombosis, outcomes of pharmacotherapy, lifestyle interventions, etc.
  • Target Audience:

    The target audience for this course is: Nurses; Pharmacists; Physicians; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.